190 related articles for article (PubMed ID: 30272964)
1. Optimization of 8-Hydroxyquinolines as Inhibitors of Catechol O-Methyltransferase.
Buchler I; Akuma D; Au V; Carr G; de León P; DePasquale M; Ernst G; Huang Y; Kimos M; Kolobova A; Poslusney M; Wei H; Swinnen D; Montel F; Moureau F; Jigorel E; Schulze MED; Wood M; Barrow JC
J Med Chem; 2018 Nov; 61(21):9647-9665. PubMed ID: 30272964
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitors.
Zhao Z; Harrison ST; Schubert JW; Sanders JM; Polsky-Fisher S; Zhang NR; McLoughlin D; Gibson CR; Robinson RG; Sachs NA; Kandebo M; Yao L; Smith SM; Hutson PH; Wolkenberg SE; Barrow JC
Bioorg Med Chem Lett; 2016 Jun; 26(12):2952-2956. PubMed ID: 27133481
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory Effect of Bovine Lactoferrin on Catechol-O-Methyltransferase.
Ikeda M; Iijima H; Shinoda I; Iwamoto H; Takeda Y
Molecules; 2017 Aug; 22(8):. PubMed ID: 28825621
[TBL] [Abstract][Full Text] [Related]
4. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
Engelbrecht I; Petzer JP; Petzer A
Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
[TBL] [Abstract][Full Text] [Related]
5. Design of Potent and Druglike Nonphenolic Inhibitors for Catechol O-Methyltransferase Derived from a Fragment Screening Approach Targeting the S-Adenosyl-l-methionine Pocket.
Lerner C; Jakob-Roetne R; Buettelmann B; Ehler A; Rudolph M; Rodríguez Sarmiento RM
J Med Chem; 2016 Nov; 59(22):10163-10175. PubMed ID: 27685665
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human catechol-O-methyltransferase-mediated dopamine O-methylation by daphnetin and its Phase II metabolites.
Liang SC; Ge GB; Xia YL; Pei-Pei D; Ping W; Qi XY; Cai-Xia T; Ling Y
Xenobiotica; 2017 Jun; 47(6):498-504. PubMed ID: 27435571
[TBL] [Abstract][Full Text] [Related]
7. Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease.
Patel CN; Georrge JJ; Modi KM; Narechania MB; Patel DP; Gonzalez FJ; Pandya HA
J Biomol Struct Dyn; 2018 Nov; 36(15):3938-3957. PubMed ID: 29281938
[TBL] [Abstract][Full Text] [Related]
8. Catechol O-methyltransferase. 8. Structure-activity relationships for inhibtion by 8-hydroxyquinolines.
Borchardt RT; Thakker DR; Warner VD; Mirth DB; Sane JN
J Med Chem; 1976 Apr; 19(4):558-60. PubMed ID: 817025
[TBL] [Abstract][Full Text] [Related]
9. Crystal Structure of Catechol O-Methyltransferase Complexed with Nitecapone.
Iijima H; Takebe K; Suzuki M; Kobayashi H; Takamiya T; Saito H; Niwa N; Kuwada-Kusunose T
Chem Pharm Bull (Tokyo); 2020; 68(5):447-451. PubMed ID: 32378542
[TBL] [Abstract][Full Text] [Related]
10. Novel, non-nitrocatechol catechol-O-methyltransferase inhibitors modulate dopamine neurotransmission in the frontal cortex and improve cognitive flexibility.
Byers S; Buchler IP; DePasquale M; Rowley HL; Kulkarni RS; Pinder L; Kolobova A; Li C; Au V; Akuma D; Zhang G; Wei H; Cheetham SC; Barrow JC; Carr GV
Psychopharmacology (Berl); 2020 Sep; 237(9):2695-2707. PubMed ID: 32474681
[TBL] [Abstract][Full Text] [Related]
11. Integrated Mass Spectrometry Reveals Celastrol As a Novel Catechol-O-methyltransferase Inhibitor.
Guo H; Yang Y; Zhang Q; Deng JR; Yang Y; Li S; So PK; Lam TC; Wong MK; Zhao Q
ACS Chem Biol; 2022 Aug; 17(8):2003-2009. PubMed ID: 35302751
[TBL] [Abstract][Full Text] [Related]
12. Nordihydroguaiaretic Acid as a Novel Substrate and Inhibitor of Catechol
Kim JH; Lee J; Jeong H; Bang MS; Jeong JH; Chang M
Molecules; 2021 Apr; 26(7):. PubMed ID: 33916785
[TBL] [Abstract][Full Text] [Related]
13. Unveiling the biopathway for the design of novel COMT inhibitors.
Cruz-Vicente P; Gonçalves AM; Barroca-Ferreira J; Silvestre SM; Romão MJ; Queiroz JA; Gallardo E; Passarinha LA
Drug Discov Today; 2022 Oct; 27(10):103328. PubMed ID: 35907613
[TBL] [Abstract][Full Text] [Related]
14. Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders.
Ma Z; Liu H; Wu B
Br J Clin Pharmacol; 2014 Mar; 77(3):410-20. PubMed ID: 23713800
[TBL] [Abstract][Full Text] [Related]
15. Insight into the Therapeutic Potential of a Bicyclic Hydroxypyridone Compound 2-[(2,4-Dichlorophenyl)methyl]-7-hydroxy-1,2,3,4-tetrahydro-8H-pyrido[1,2-a]pyrazin-8-one as COMT Inhibitor in the Treatment of Parkinson's Disease: A Molecular Dynamic Simulation Approach.
Subair TI; Akawa OB; Soremekun OS; Olotu FA; Soliman MES
Chem Biodivers; 2021 Sep; 18(9):e2100204. PubMed ID: 34252268
[TBL] [Abstract][Full Text] [Related]
16. A semiempirical study on inhibition of catechol O-methyltransferase by substituted catechols.
Ovaska M; Yliniemelä A
J Comput Aided Mol Des; 1998 May; 12(3):301-7. PubMed ID: 9749372
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of 3-hydroxypyridin-4-ones as inhibitors of catechol-O-methyltransferase.
de Beer J; Petzer JP; Lourens ACU; Petzer A
Mol Divers; 2021 May; 25(2):753-762. PubMed ID: 32108308
[TBL] [Abstract][Full Text] [Related]
18. Distribution, properties, and inhibitor sensitivity of zebrafish catechol-O-methyl transferases (COMT).
Semenova S; Rozov S; Panula P
Biochem Pharmacol; 2017 Dec; 145():147-157. PubMed ID: 28844929
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Selected Natural Compounds as Dual Inhibitors of Catechol-O-Methyltransferase and Monoamine Oxidase.
Engelbrecht I; Petzer JP; Petzer A
Cent Nerv Syst Agents Med Chem; 2019; 19(2):133-145. PubMed ID: 31258092
[TBL] [Abstract][Full Text] [Related]
20. Membrane bound catechol-O-methytransferase is the dominant isoform for dopamine metabolism in PC12 cells and rat brain.
Su Y; DePasquale M; Liao G; Buchler I; Zhang G; Byers S; Carr GV; Barrow J; Wei H
Eur J Pharmacol; 2021 Apr; 896():173909. PubMed ID: 33503461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
